Human uremic plasma increases microvascular permeability to water and proteins in vivo  by Harper, Steven J. et al.
Kidney International, Vol. 61 (2002), pp. 1416–1422
VASCULAR BIOLOGY – HEMODYNAMICS – HYPERTENSION
Human uremic plasma increases microvascular permeability to
water and proteins in vivo
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Human uremic plasma increases microvascular permeability to vascular remodeling [4]. The reasons that underlie
to water and proteins in vivo. this aggressive pathology are unknown but are presumed
Background. The risk of cardiovascular disease is signifi- to be multifactorial.cantly higher in patients with long-term uremia than in other-
In uremia the conventional vascular risk factors (bloodwise healthy adults. This is true even before patients proceed
pressure, dyslipidemia, salt intake, smoking) are man-to dialysis, but the reason why cardiovascular risk is increased
is unknown. Transvascular transport of lipids and other macro- aged in as a robust manor as the clinical state allows.
molecules in both large vessels and the microcirculation has However, even in large studies, these classical risk factors
been implicated in generation of cardiovascular disease. do not seem to explain much of the increased cardiovas-Methods. To determine whether patients with long-term
cular risk apparent in chronic renal disease [5]. In moreuremia have circulating factors that promote increased vascular
permeability, we measured the effect of perfusing microvessels recent years, therefore, attention has fallen on numerous
with uremic plasma in a non-mammalian model of vascular other less conventional risk factors present in the uremic
permeability measurement. population [6]. The contribution of any or all of these
Results. Perfusion of frog mesenteric microvessels with dia-
factors is still contentious.lyzed normal plasma did not result in an increase in either
The pathogenesis of atherosclerosis results from ahydraulic conductivity (Lp, permeability of the vessel wall to
water) or oncotic reflection coefficient (, permeability to mac- complex interaction of platelets, macrophages, endothe-
romolecules, particularly proteins). Perfusion with dialyzed lial and smooth muscle cells and over 20 growth factors
uremic plasma resulted in a very significant increase in vascular and cytokines produced by these cell types [7]. In addi-permeability to both water (Lp increased 8.8-fold from 4.1 to
tion there is now increasing evidence that endothelial36.4  107 cm s1 cm H2O1) and proteins ( reduced from
function is abnormal in uremia. High levels of endothe-0.93 to 0.53).
Conclusions. These results suggest that one or more circulat- lial cell-derived glycoproteins [such as von Willebrand
ing macromolecules in uremic plasma are able to increase trans- factor (vWF), tissue-type plasminogen activator (t-PA),
vascular solute and fluid flux, and may underlie the increased
urokinase-type plasminogen activator (u-PA), solublecardiovascular risk found in these patients.
thrombomodulin] have been detected in uremia in addi-
tion to an impaired release of such compounds to a
Long-term uremia is associated with a greatly in- recognized stimulus (vasopressin) [8]. There also are
creased risk of vascular disease and premature death com- physiological data to suggest that endothelium-depen-
pared with the general population [1]. This increased risk dent vasodilation of conduit arteries is reduced in both
is present in both dialysis and non-dialysis–dependent re- hemodialysis and continuous ambulatory peritoneal dial-
nal failure [2], and may be up to one hundred-fold in ysis (CAPD) patients [9, 10].
certain patient groups [3]. The premature vascular dis- Furthermore, there is accumulating evidence that the
ease that accompanies chronic renal insufficiency ap- uremic milieu itself may be pro-atherogenic. Uremic
pears to be both macrovascular and microvascular, and serum has been shown to inhibit interleukin-1 (IL-1)
is associated with reduced arterial compliance secondary and tumor necrosis factor- (TNF-) (endothelial and
smooth muscle cell cytokines) dependent production of
plasminogen activating inhibitor type I by cultured endo-Key words: capillary permeability, uremia, kidney disease, vascular
endothelium, cardiovascular disease, transvascular transport. thelial cells [11]. Urea in physiologically relevant concen-
trations has been shown to enhance cultured macro-Received for publication July 5, 2001
phage proliferation by the inhibition of inducible nitricand in revised form October 5, 2001
Accepted for publication November 2, 2001 oxide synthase (iNOS)-dependent nitric oxide (NO) pro-
duction, thus reducing NO-dependent macrophage apo- 2002 by the International Society of Nephrology
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ptosis [12]. Further work has demonstrated that acidosis animals were anesthetized by immersion in 1 mg/mL
MS222 (3-aminobenzoic acid ethyl ester) in water, and(common in uremia) may increase the endothelial cell
production of relevant growth and permeability stimu- anesthesia was maintained by superfusion with 0.1 mg/mL
MS222 in frog Ringer’s solution [111 mmol/L NaCl, 2.4lants, including vascular endothelial growth factor [13].
To address the possibility that factors that circulate mmol/L KCl, 1 mmol/L MgSO4, 1.1 mmol/L CaCl2, 0.20
mmol/L NaHCO3, 2.63 mmol/L N-2-hydroxyethylpi-in uremia may influence endothelial permeability, we
studied the effect of perfusing capillaries with uremic perazine-N-2-ethanesulphonic (HEPES) acid, and 2.37
mmol/L HEPES sodium salt]. The animal was then laidand non-uremic human plasma. Changes in endothelial
hydraulic conductivity (a measure of endothelial per- supine and the limbs lightly secured. A small incision (8
to 10 mm) was made in the right lateral skin and muscu-meability to water and small solutes) and reflection co-
efficient (an assessment of endothelial pore size and lar body wall. The distal ileum was floated out and care-
fully draped over a 1 cm diameter transparent Perspexresistance to the passage of large molecules) were deter-
mined by the use of the modified Landis technique [14], pillar. The pH of this solution was 7.40  0.02 at room
temperature. The microvessels in the mesentery werethe only method capable of providing true in vivo func-
tional data on hydraulic conductivity and reflection co- visualized under a Leitz inverted microscope (Leitz
DMIL; Leitz, Wetzlar, Germany). A video camera (Pan-efficient simultaneously. Techniques based on Evans
blue-albumin (the Miles assay) do not measure perme- asonic WVBP32; 8 mm) was attached to the top of the
microscope to allow binocular visualization and simulta-ability [15].
neous recording of a 270 m segment of the vessel (out
of a total length of 800 to 2000 m). The video was
METHODS
connected through an electronic timer (ForA VT33) to a
Samples video cassette recorder (Panasonic AG7350). The upper
surface of the mesentery was kept continuously super-Five normotensive patients with chronic uremia that
did not require dialysis were matched for age with non- fused with frog Ringer’s solution during the entire time
that it was exposed. All experiments were done at roomsmoking healthy volunteers. None of the patients were
diabetic or smokers, although three had smoked in the temperature (20 to 22C).
past. Causes for chronic renal failure were glomerulone-
Measurement of hydraulic conductivity (Lp)phritis (N 	 3), accelerated phase hypertension (1) and
reflux nephropathy (1). A uniform blood collection pro- The Lp of isolated perfused mesenteric microvessels
was measured using the Landis micro-occlusion methodcedure was used using vacutainers. Blood samples were
taken directly into lithium heparin tubes for permeability that has been previously described [14] and extensively
discussed in the literature [16], and adapted to measurestudies, ethylenediaminetetraacetic acid (EDTA) for
complement studies (measured on a Behring Nephelom- rapid changes in Lp, and chronic changes in Lp [17]. Mi-
crovessels were selected that had freely flowing blood,eter). These were then spun at 10,000 rpm for ten minutes
and the plasma separated into a second tube. Approxi- no white cells adhering or rolling along the wall, and a
length of at least 800 m with no side branches. Mi-mately 0.5 mL of plasma was left in the tube above the
buffy coat to avoid contamination. The samples were crovessels chosen for Lp measurement were either true
capillaries (divergent flow at one end and convergent atstored at 20C until used. After thawing the samples
were dialyzed against frog Ringer’s solution using 12,000 the other), or first order venules (convergent flow from
two true capillaries at one end and convergent flow atMW dialysis tubing to correct for hypotonic [Na
] in
frogs and filtered through a 0.2 m filter. All samples the other), and had a diameter of 18 to 25 m. The vessel
was cannulated with a glass micropipette (pulled andwere only frozen/thawed once before use. At the time
of venesection, patients and controls had further samples ground from glass capillary tubes, outer diameter 1.5
mm; Clark ElectroMed, UK) filled with a low hematocrittaken for biochemical and lipid analyses [urea, creati-
nine, albumin, total protein, cholesterol, triglycerides, (1%) human red blood cells as flow markers in either
5% human serum albumin (HSA) in frog Ringer’s solu-high-density lipoprotein (HDL), low-density lipoprotein
(LDL); calcium and sugar levels were determined, and tion or human plasma dialyzed with frog Ringer’s solu-
tion. The red cells (type O) were collected as describedthese were collected into the appropriate vacutainers].
above and washed three times in frog Ringer’s solution
Permeability studies before use. The micropipette was clamped in a holder
(WPI Instruments, Stevenage, UK) with a side port at-Microvascular permeability was measured using the
Landis Michel technique in male leopard frogs (Rana tachment and connected to a water manometer. The
vessel was occluded with a glass rod held by a microma-temporaria, 20 to 35 g; supplied by Blades, UK). All
chemicals were purchased from Sigma Chemical Company nipulator, and the pressure in the pipette was reduced by
10 cm H2O from one pressure (P2) to another (P1) and(Poole, Edenbridge, UK) unless otherwise specified. The
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then switched back again over a period of 3 to 7 seconds. perfused with 5% HSA or plasma [19].  is the pres-
sure at which no filtration occurs. This was calculatedThe glass rod was then removed, and the vessel allowed
to flow freely for at least 7 seconds before another occlu- according to the Starling equation as:
sion was made. The occlusion site was moved up the
 	 P1 [(Jv/A1)/Lp] (Eq. 4)vessel after every three blocks, or if leakage was observed
around the block site. Once measurements had been Oncotic reflection coefficient was calculated as de-
scribed by Michel and Phillips [20]:made using one set of plasma, the perfusate was switched
to a second subject’s plasma with a pipette refilling unit
 	 (/c) (Eq. 5)previously described [18].
c was measured using a modified Hansen oncometer,
Calculation of Lp and oncotic reflection coefficient as previously described (abstract; Bates et al, J Physiol
438:11, 1991).The transcapillary water flow per unit area of capillary
wall (Jv/A) was calculated from the velocity of the red
Immunohistochemistrycells (dl/dt) after occlusion, the capillary radius (r) and
the length between the marker cell and the point of Immunohistochemistry for the Gal 1:3Gal epitope
was performed using a lectin based system. Frog mesen-occlusion (l), all of which were measured off line from
the audio-videotape. tery, liver and aorta were studied in a composite block
and pig islets were used as a positive control (kindly
(Jv/A) 	 (dl/dt) (r/(2 l) (Eq. 1)
donated by Dr. Richard Smith). Frozen sections were
fixed in acetone for five minutes and allowed to air dry.The filtration rate was calculated at all pressures (P2
twice and P1) and Jv/A for the two measurements at P2 The slides were flooded with blocking solution [3% bo-
vine serum albumin (BSA), 0.1% Triton-X-100, in Tris-averaged to give filtration rates at two different pressures
(Jv/A2 at P2, and Jv/A1 at P1), and the hydraulic conduc- buffered saline (TBS)], and then biotin-labeled Bandeir-
tivity (Lp) and oncotic reflection coefficient () calcu- aea Simplicifolia lectin diluted 1:20 lectin with blocking
lated from the Starling equation: solution for 30 minutes. After a further wash in blocking
solution, the slides were flooded with Texas Red-strep-(Jv/A) 	 Lp [(Pc Pi)  (c i)] (Eq. 2) tavidin conjugate 1:40 in blocking solution. After a final
where Pc is the capillary hydrostatic pressure, Pi is the wash the slides were left in running tap water for 10
interstitial hydrostatic pressure,c is the oncotic pressure minutes and mounted in aqueous mounting medium.
in the capillary (that is, that of the plasma), and i is Slides were then visualized on a Nikon Optiphot UV
the oncotic pressure in the interstitium. When Jv/A is microscope.
measured at two pressures (P1 and P2), Statistics and ethics. All sample collection was under-
taken with local Ethical Committee Approval and animalLp	 (Jv/A2 Jv/A1)/(P2 P1) (Eq. 3) experiments conducted under Home Office License. Hy-
assuming that Pi, , c, i and Lp do not change between draulic conductivity measurements were not normally
measurements. Jv/A2 is the average of measurements at distributed, so non-parametric statistics were used to
time t1, and t3. Jv/A1 is measured at t2, and the average compare the increases in permeability. Wilcoxon paired
of t1 and t3 is t2. Therefore, Jv/A2 minus the average tests and Mann-Whitney U unpaired tests were used,
filtration rate at t1 and t3 will be a reasonable approxima- and P 0.05 was taken as significant. Mean fold changes
tion of what it would have been at t2. This means that are the increased Lp divided by the baseline Lp for
Equation 3 is valid even when Jv/A is rapidly changing. each vessel; therefore, the mean increase in Lp will not
This can be shown to be correct since the measurements necessarily equal the increase of the mean Lp.
are made within 3 to 7 seconds of each other. The rate
of change of filtration rate per unit area [d(Jv/A)/dt]
RESULTSduring the increases in permeability described in the
All patients had creatinine clearances below 35 mL/uremic patients was 0.004  0.0016  103 m · s-2.
min (Cockroft-Gault formula). Plasma creatinines wereTherefore, the total change in Jv/A during the measure-
in the range of 174 to 755 m/L, and urea ranged fromment period would be an order of magnitude lower than
15.4 to 36.2 mmol/L. All patients had plasma albumin,Jv/A measured during these conditions (0.03 to 2.6
total protein, free calcium, and blood glucose levels inm · s-1).
the normal range. Patients demonstrated a modest hy-
Measurement of oncotic reflection coefficient percholesterolemia (mean 6 mmol/L, upper limit advised
a range of 5.2 mmol/L) and hypertriglyceridemia (meanThe effective oncotic pressure difference () and
2.1 mmol/L, upper limit advised a range of 1.8 mmol/L)reflection coefficient were calculated from the filtration
rates measured as described above when the vessel was commensurate with their impaired renal function [21].
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HDL and LDL levels were within the advised range
in patients. All biochemical and lipid parameters were
normal in controls. Of note, the albumin levels were very
similar in controls (range 40 to 47 g/L) and patients
(range 38 to 48 g/L). C3 C4 complement levels were all
within the normal reference range as were Cdc levels
(patients 	 39 to 134 mg/L, patients 30 to 128 mg/L).
Measurement of sodium, potassium, calcium, albumin
urea and creatinine was carried out on plasma samples
after dialysis with frog Ringer’s solution. Dialysis re-
sulted in a normalization of sodium, calcium and potas-
sium concentrations to frog Ringer’s levels. Plasma urea
was reduced to under 1 mm/L and creatinine to under
40 mol/L.
Colloid osmotic pressure. The 5% HSA had a colloid
Fig. 1. Effect of normal plasma on the capillary filtration rate. Filtration
osmotic pressure (COP) of 23 cm H2O. Patients and rate data per unit area (Jv/A) of a single perfused capillary during
perfusion of normal plasma are from two different subjects. Measure-controls had similar COPs (patients, mean 28.4, range
ments were made at two different pressures, 40 cm H2O () and 3027 to 30 cm H2O vs. controls, mean 27.6, 25 to 34 cm cm H2O (). No increase in permeability was detected.
H2O).
Effect on hydraulic conductivity of perfusion with
vessels with uremic plasma was 36.4  8.8, significantlynormal plasma
higher than vessels perfused with either normal plasmaHydraulic conductivity was measured in eleven vessels
or human serum albumin (P  0.05, Mann-Whitney Uthat were perfused with normal human plasma. The
test; Fig. 4A).mean Lp during perfusion with normal human plasma
was 4.1  0.9  107 cm s1 cm H2O1. This was not Effect on reflection coefficient of perfusion with
significantly different from recently published values of normal or uremic plasma
Lp measured on Rana temporaria mesenteric vessels per- Oncotic reflection coefficient to perfusate macromole-fused with 5% BSA under identical circumstances (mean
cules () was measured in eleven vessels perfused with
Lp of 3.4  1.7  107 cm · s1 · cm H2O1) [22]. It is also normal human plasma. The mean  during perfusion
within the normal range of Lp measured in these vessels with normal human plasma was 0.93  0.05, and this
from numerous studies in the literature, which vary from was not significantly different from that of vessels per-
1 to 10  107cm s1 cm H2O1 [23]. Perfusion of vessels fused with 5% HSA (0.95  0.02, P  0.05, Mann-
for over five minutes showed no increase in permeability Whitney U test). It is also within the normal range of
with normal human plasma. Reperfusion with plasma reflection coefficients measured in these vessels, which
from a different individual also did not increase Lp. Per- vary from 0.8 to 0.99. Recently published values of 
fusion of one vessel with two different control subjects measured on Rana temporaria mesenteric vessels per-
plasma resulted in a slight reduction from 6.2 to 3.8  fused with 5% BSA under identical circumstances gave
107 cm · s1 · cm H2O1 (Fig. 1). Perfusion with plasma a mean  of 0.87  0.02 [22]. Reperfusion with plasma
after HSA did not change permeability either. In two from a different individual also did not change the re-
vessels perfused with HSA and then normal plasma, the flection coefficient.
Lp did not change (7.8  1.6 to 7.8  1.3  107 cm s1 In contrast, perfusion with uremic plasma resulted in
cm H2O1). a marked reduction in oncotic reflection coefficient from
0.93  0.02 in the eleven vessels perfused with normal
Effect on hydraulic conductivity of perfusion with plasma to 0.53 0.02 while perfused with uremic plasma.
uremic plasma In four vessels where  was measured with 5% HSA or
Perfusion of eight vessels with uremic plasma resulted normal plasma and then with uremic plasma, there was
in a significant, 23.8  8.2-fold increase in filtration rate a significant reduction in all four vessels from a mean of
per unit area of capillary wall. An example of one of 0.94 0.04 to 0.47 0.16, (P 0.05 paired t test; Fig. 4B).
these vessels is shown in Figure 2A. In five vessels, the An example of the reflection coefficient measurements in
hydraulic conductivity as well as the filtration rate could a single vessel is shown in Figure 3.
be measured by altering the pressure and calculating the
Immunohistochemistryslope of filtration rate per unit area against pressure. An
example of the Lp measurements made on a single vessel The Gal 1:3Gal epitope was detectable on pig islet
vasculature but not frog tissue.is shown in Figure 2B. Mean Lp during perfusion of
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Fig. 3. Effect of uremic plasma on oncotic reflection coefficient. Perfu-
sion of a vessel with uremic plasma decreased the  of a single perfused
mesenteric capillary.
are unable to account for changes in capillary surface
area. Although this experiment involved a cross-species
interaction (human plasma and red cells and frog endo-
thelium), the hydraulic conductivity of frog capillaries
has been shown to increase in response to factors that are
believed to increase endothelial permeability in humans
(such as, human vascular endothelial growth factor) [17].
Therefore, we hypothesize that in uremia, in humans, a
chronic alteration in endothelial permeability may be an
important pathogenic mechanism underlying the prema-
ture vascular disease seen in this clinical group. Further-
more, we propose that a chronic increase in endothelialFig. 2. (A) Effect of uremic plasma on the capillary filtration rate.
Filtration rate data per unit area (Jv/A) of a single perfused capillary permeability may be at least one process by which recog-
during perfusion of plasma are from one healthy subject followed by nized vascular risk factors act in uremia, particularly ifplasma from a patient with chronic uremia. Measurements were made
the endothelium is rendered more permeable to sub-at 50 cm H2O (), 45 cm H2O (), 40 cm H2O (), 35 cm H2O (),
30 cm H2O (), 25 cm H2O () and 10 cm H2O (). The hydraulic stances such as albumin and LDL. However, we believe
conductivity (Lp) appeared to increase and  appeared to decrease, that the putative changes in hydraulic conductivity andconsistent with a significant increase in vascular permeability. (B) Effect
of uremic plasma on hydraulic conductivity. Perfusion of a vessel with reflection co-efficient we propose in humans are unlikely
uremic plasma increased Lp of a single perfused mesenteric capillary. to be of the same order of magnitude, since changes of
this degree in humans would probably be exceedingly
harmful. The results from the uremic patients contrasted
sharply with those of the controls. Although there is oneDISCUSSION
abstract published where investigators measured in-These study results, to our knowledge, are the first in
creases in endothelial permeability in this model in re-vivo functional data to suggest that uremia per se inter-
sponse to human plasma from two apparently healthyferes with the physiology of endothelial permeability.
subjects (abstract; Adamson RH, J Physiol (Lond) 426,Our data suggest that this is true for water as well as
115P, 1990), we were unable to reproduce this finding.macromolecules. We chose to study the response of frog
Despite the fact that some vessels were perfused for overcapillaries using the Landis technique, since it is a well-
30 minutes with normal human plasma, no significantestablished technique shown to be robust, reliable and
changes in hydraulic conductivity or reflection co-effi-produce accurate reproducible measurements of hy-
cient were seen. In contrast, perfusion with uremicdraulic conductivity and refection co-efficient [24]. In
plasma produced changes within three to five minutes.addition, there is no way of measuring microvascular
Of note, the changes in permeability we documentedpermeability coefficients in humans in vivo that is not
were seen using plasma that was derived from patientscomplicated by changes in surface area available for ex-
in whom the serum albumin was well maintained withinchange, or hemodynamic factors. Although capillary fil-
tration coefficients can be estimated, the methods used the normal range and in whom the colloid osmotic pres-
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Fig. 4. (A) Hydraulic conductivity (Lp) of
frog mesenteric microvessels. Vessels were
perfused with 5% human serum albumin
(HSA), normal plasma or uremic plasma. Per-
meability was significantly greater during per-
fusion with uremic plasma than with normal
plasma or HSA. (B) Reflection coefficient ()
of frog mesenteric microvessels. Vessels were
perfused with 5% HSA, normal plasma or
uremic plasma.  was significantly lower, and
therefore permeability was significantly greater
during perfusion with uremic plasma than with
normal plasma or HSA. Data are mean 
SEM.
sure was comparable to that of controls, and that had was demonstrated in patients compared to controls, and
C3, C4 and C3c levels were comparable. Furthermore,been dialyzed against frog Ringer’s solution using tubing
with a molecular weight cut off of 12 kD. Therefore, any the Gal 1:3Gal epitope was not found on the frog endo-
thelium, nor are we aware of any such description in anyincrease in permeability brought about by perfusion with
uremic plasma is likely to be due to macromolecules amphibian in the literature.
A number of important questions arise from theserather than smaller molecular weight substances such as
urea or homocysteine. Although the controls and pa- data. Firstly, which constituent or constituents of human
uremic plasma produce the response seen in this study?tients were matched as closely as possible, one clear
difference was noted in the medication received. We are There are many potential candidates [LDL, vascular en-
dothelial growth factor (VEGF), acute phase inflamma-aware of no evidence that would support the hypothesis
that the changes documented here could have resulted tory cytokines, asymmetrical dimethylarginine (ADMA),
advanced glycation end products (AGEs), advancedfrom the long-standing medication of the uremic pa-
tients. The only medication common to the uremic group lipo-oxidation products (ALEs)]. Since epidemiological
studies suggest that risk factors for uremic cardiovascularwas iron and folate supplements. Two patients were on
erythropoietin and one on meloxicam (COX-2 inhibi- disease (as far as is understood) may be additive [26], it
seems reasonable to hypothesize that more than onetor). All were on a variety of antihypertensive drugs
that included: candesartan, an angiotensin II blocker (2 factor may contribute to the effects we have demon-
strated. Secondly, to what pro-atherogenic factors doespatients); perindopril, an angiotensin converting enzyme
inhibitor (1 patient); atenolol, a  blocker (1 patient); an endothelium become more permeable? For example,
should oxidized LDL be shown to cross such an endothe-doxazocin, an  blocker (2 patients); nifedipine, CaCB
(1 patient). A number of these agents are vasoactive lium at an accelerated rate, this would be strong evidence
to support the notion that altered endothelial permeabil-(constrictors/dilators) and may affect capillary filtration
coefficients measured in a capillary bed. However, the ity is one of the factors that significantly contributes to
the vascular disease of uremic patients. Further detailedLandis technique is not subject to these types of errors
because the cannulated capillary is of a fixed surface functional in vivo studies will be required to address
area; therefore, no errors in transendothelial filtration these issues.
rates due to capillary recruitment are possible. In addi-
tion, nifedipine has no direct action on endothelial cells ACKNOWLEDGMENTS
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